배경: 한국인의 Human Neutrophil Alloantigen-1 (HNA-1), HNA-2, HNA-4, HNA-5 유전자 빈도에대한 연구는 혈청학적 혹은 분자유전적 방법을이용하여 이미 이루어졌으나 HNA-3의 유전자 빈도는 아직 연구되지 ...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A104782954
2015
Korean
KCI등재후보
학술저널
185-192(8쪽)
0
0
상세조회0
다운로드국문 초록 (Abstract)
배경: 한국인의 Human Neutrophil Alloantigen-1 (HNA-1), HNA-2, HNA-4, HNA-5 유전자 빈도에대한 연구는 혈청학적 혹은 분자유전적 방법을이용하여 이미 이루어졌으나 HNA-3의 유전자 빈도는 아직 연구되지 ...
배경: 한국인의 Human Neutrophil Alloantigen-1 (HNA-1), HNA-2, HNA-4, HNA-5 유전자 빈도에대한 연구는 혈청학적 혹은 분자유전적 방법을이용하여 이미 이루어졌으나 HNA-3의 유전자 빈도는 아직 연구되지 않았다. 저자들은 이번 연구에서 한국인의 HNA-3a의 유전자빈도를 확인하여 HNA-3a (HNA-3b) 동종면역위험률과 HNA-3 부적합률을 계산하고 HNA-3항체검사에 사용할과립구를 제공할 공혈자를 확보하고자 하였다.
방법: 저자들은 110명의 건강한 비혈연 한국인공혈자의 HNA-3유전자를 염기서열특이-중합효소연쇄반응 이용하여 검사하였다.
결과: 한국인의 HNA-3a, HNA-3b 유전자 빈도는 각각 0.695와 0.305였다. 이 중 HNA-3a유전자빈도가 미국 백인, 독일인보다 통계적으로 유의하게 낮았다(P<0.05). 임신(수혈)에 의한 HNA-3a 동종면역위험률과 HNA-3b 동종면역위험률은 각각0.065 (0.084), 0.147 (0.250)였고 한국인의 HNA-3a 동종면역위험률은 미국 백인, 독일인에 비해 유의하게 높았다(P<0.05).
결론: 저자들은 한국인에서 HNA-3 유전자 빈도, 임신 혹은 수혈에 의한 HNA-3a 동종면역위험률과 HNA-3b동종면역위험률을 확인하였고HNA-3 항체검사에 사용할 과립구 패널에 HNA-3a/3a, HNA-3b/3b 과립구를 제공할 공혈자를 확인하였다.
다국어 초록 (Multilingual Abstract)
Background: In the Korean population, gene frequencies of Human Neutrophil Alloantigen-1 (HNA-1), HNA-2, HNA-4, and HNA-5 were determined using serological and genotyping methods. However, no study assessing the gene frequencies of HNA-3 among the Kor...
Background: In the Korean population, gene frequencies of Human Neutrophil Alloantigen-1 (HNA-1), HNA-2, HNA-4, and HNA-5 were determined using serological and genotyping methods. However, no study assessing the gene frequencies of HNA-3 among the Korean population has been conducted. The aims of this study were to report the gene frequencies of HNA-3, to estimate the risk of HNA-3a (or HNA-3b) alloimmunization, and to secure donors of granulocytes for anti-HNA-3 antibodies among the Korean population.
Methods: Genotyping of HNA-3a and HNA-3b genes of 110 healthy and unrelated Korean donors was performed using a polymerase chain reaction with sequence-specific primers.
Results: The observed frequencies of HNA-3a and HNA-3b were 0.695 and 0.305, respectively, among the Korean population. The HNA-3a gene frequency of Koreans was significantly lower than those of American Whites and Germans (P<0.05). The risk of HNA-3a and HNA-3b alloimmunization due to pregnancy (transfusion) was 0.065 (0.084) and 0.147 (0.250), respectively, among the Korean population. The risk of HNA-3a alloimmunization was significantly higher in the Korean population than in the German and American White populations (P<0.05).
Conclusion: The gene frequencies of HNA-3 and the risk of HNA-3a (HNA-3b) alloimmunization due to pregnancy or transfusion among the Korean population were determined. We also identified individuals who were HNA-3a/3a or HNA-3b/3b for the granulocyte panel which could be used for anti-HNA antibody identification.
참고문헌 (Reference)
1 한태희, "한국인에서 과립구항원 HNA-4a와 HNA-5a 유전자 빈도" 대한진단검사의학회 26 (26): 114-118, 2006
2 Matsuo K., "Variations in the expression of granulocyte antigen NB1" 40 : 654-662, 2000
3 Curtis BR., "The neutrophil alloantigen HNA-3a(5b)is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution" 115 : 2073-2076, 2010
4 Xia W., "The frequencies of human neutrophil alloantigens in the Chinese Han population of Guangzhou" 51 : 1271-1277, 2011
5 Matsuhashi M., "The frequencies of human neutrophil alloantigens among the Japanese population" 80 : 336-340, 2012
6 Davoren A., "TRALI due to granulocyte-agglutinating human neutrophil antigen-3a(5b)alloantibodies in donor plasma : a report of 2 fatalities" 43 : 641-645, 2003
7 Jutzi M., "Swiss haemovigilance data and implementation of measures for the prevention of transfusion associated acute lung injury(TRALI)" 35 : 98-101, 2008
8 Chapman CE., "Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma" 49 : 440-452, 2009
9 Seeger W, "Reproduction of transfusion-related acute lung injury in an ex vivo lung model" 76 : 1438-1444, 1990
10 ISBT Working Party on Granulocyte Immunobiology., "Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury" 96 : 266-269, 2009
1 한태희, "한국인에서 과립구항원 HNA-4a와 HNA-5a 유전자 빈도" 대한진단검사의학회 26 (26): 114-118, 2006
2 Matsuo K., "Variations in the expression of granulocyte antigen NB1" 40 : 654-662, 2000
3 Curtis BR., "The neutrophil alloantigen HNA-3a(5b)is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution" 115 : 2073-2076, 2010
4 Xia W., "The frequencies of human neutrophil alloantigens in the Chinese Han population of Guangzhou" 51 : 1271-1277, 2011
5 Matsuhashi M., "The frequencies of human neutrophil alloantigens among the Japanese population" 80 : 336-340, 2012
6 Davoren A., "TRALI due to granulocyte-agglutinating human neutrophil antigen-3a(5b)alloantibodies in donor plasma : a report of 2 fatalities" 43 : 641-645, 2003
7 Jutzi M., "Swiss haemovigilance data and implementation of measures for the prevention of transfusion associated acute lung injury(TRALI)" 35 : 98-101, 2008
8 Chapman CE., "Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma" 49 : 440-452, 2009
9 Seeger W, "Reproduction of transfusion-related acute lung injury in an ex vivo lung model" 76 : 1438-1444, 1990
10 ISBT Working Party on Granulocyte Immunobiology., "Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury" 96 : 266-269, 2009
11 de Haas M., "Neutrophil antigen 5b is carried by a protein, migrating from 70 to 95 kDa, and may be involved in neonatal alloimmune neutropenia" 40 : 222-227, 2000
12 Lalezari P., "Identification of a specific leukocyte antigen : another presumed example of 5b" 5 : 135-142, 1965
13 Bux J, "ISBT Working Party on Platelet and Granulocyte Serology, Granulocyte Antigen Working Party" International Society of Blood Transfusion 39 : 662-663, 1999
14 De La Vega Elena CD., "Human platelet-specific antigens frequencies in the Argentinean population" 18 : 83-90, 2008
15 Moritz E., "Human neutrophil alloantigens systems" 81 : 559-569, 2009
16 Bux J., "Human neutrophil alloantigens" 94 : 277-285, 2008
17 Sachs UJ., "Human alloantibody anti-Mart interferes with Mac-1-dependent leukocyte adhesion" 104 : 727-734, 2004
18 Curtis BR., "HNA-3a-specific antibodies recognize choline transporter-like protein-2 peptides containing arginine, but not glutamine at Position 154" 51 : 2168-2174, 2011
19 Sachs UJ., "Genotyping of human neutrophil antigen-5a(Ond)" 15 : 115-117, 2005
20 Reil A., "Genoand phenotyping and immunogenicity of HNA-3" 51 : 18-24, 2011
21 Han KS., "Frequency of neutrophilspecific antigens among Koreans using the granulocyte indirect immunofluorescence test(GIFT)" 13 : 15-16, 1997
22 Keller-Stanislawski B., "Frequency and severity of transfusionrelated acute lung injury--German haemovigilance data(2006-2007)" 98 : 70-77, 2010
23 Flesch BK., "FCGR3 variants and expression of human neutrophil antigen-1a, -1b, and-1c in the populations of northern Germany and Uganda" 42 : 469-475, 2002
24 Hessner MJ., "Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers" 36 : 895-899, 1996
25 Greinacher A., "Characterization of the human neutrophil alloantigen-3a" 16 : 45-48, 2010
말초혈액 조혈모세포 가동화시 골격통과 CD34 양성세포 채집량의 관계
NAT 시행 이후 C형 간염바이러스 수혈감염위험도의 변화
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2028 | 평가예정 | 재인증평가 신청대상 (재인증) | |
2022-01-01 | 평가 | 등재학술지 유지 (재인증) | ![]() |
2019-01-01 | 평가 | 등재학술지 유지 (계속평가) | ![]() |
2016-01-01 | 평가 | 등재학술지 선정 (계속평가) | ![]() |
2015-01-01 | 평가 | 등재후보학술지 유지 (계속평가) | ![]() |
2013-01-01 | 평가 | 등재후보학술지 유지 (기타) | ![]() |
2012-01-01 | 평가 | 등재후보 1차 FAIL (기타) | ![]() |
2011-01-01 | 평가 | 등재후보학술지 유지 (등재후보1차) | ![]() |
2009-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.19 | 0.19 | 0.17 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.18 | 0.16 | 0.267 | 0.03 |